G L King Selected Research

G L King Research Topics

5	Hyperglycemia 01/2023 - 07/2000
4	Insulin Resistance 01/2023 - 02/2000
3	Diabetic Retinopathy (Retinopathy, Diabetic) 12/2001 - 07/2000
2	Diabetic Angiopathies (Diabetic Angiopathy) 08/2007 - 12/2001
2	Diabetic Nephropathies (Diabetic Nephropathy) 08/2007 - 03/2000
2	Diabetes Mellitus 01/2001 - 01/2000
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2000 - 03/2000
1	Periodontitis 01/2023
1	Alveolar Bone Loss 01/2023
1	Obesity 06/2014
1	Inflammation (Inflammations) 06/2014
1	Vomiting 08/2013
1	Diabetes Complications 08/2007
1	Diabetic Neuropathies (Diabetic Neuropathy) 05/2001
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2001
1	Fibrosis (Cirrhosis) 12/2000
1	Hypoxia (Hypoxemia) 11/2000
1	Albuminuria 03/2000
1	Type 2 Diabetes Mellitus (MODY) 03/2000
1	Vascular Diseases (Vascular Disease) 01/2000

3	Protein Isoforms (Isoforms)IBA 08/2007 - 07/2000
3	Protein Kinase CIBA 08/2007 - 01/2000
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2001 - 12/2000
2	Insulin (Novolin)FDA Link 01/2023 - 06/2014
2	DiglyceridesIBA 08/2007 - 01/2000
2	Retinaldehyde (Retinal)IBA 12/2000 - 11/2000
2	Protein Kinase C betaIBA 07/2000 - 03/2000
1	Insulin ReceptorIBA 01/2023
1	Protons (Proton)IBA 08/2013
1	Advanced Glycation End ProductsIBA 08/2007
1	polyolIBA 08/2007
1	Hormones (Hormone)IBA 01/2001
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2001
1	Angiotensin IIIBA 01/2001
1	Connective Tissue Growth FactorIBA 12/2000
1	MitogensIBA 12/2000
1	von Willebrand FactorIBA 11/2000
1	Streptozocin (Streptozotocin)FDA Link 03/2000
1	Messenger RNA (mRNA)IBA 03/2000
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 03/2000
1	Proteins (Proteins, Gene)FDA Link 03/2000
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 02/2000

1	Therapeutics 12/2001
1	Glycemic Control 01/2001